- Dec 16, 2021
NCT05160584: A Study of Real-Life Current Standards of Care in Participants With RRMM (MoMMent)
NCT05160584: A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma (MoMMent)...
170
- Dec 16, 2021
NCT05050097: Phase 1 - A Study of Talquetamab With Other Anticancer Therapies in Multiple Myeloma
Talquetamab Phase 1b study NCT05050097: phase 1 - A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple...
374
- Dec 15, 2021
NCT05064787: Evaluating the Feasibility of a Digital Health Coaching Program Post CART
NCT05064787: Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy The aim of this...
85
- Dec 15, 2021
Multiple Myeloma Research Foundation - MMRF - Multiple Myeloma Precursor Conditions
Multiple Myeloma Precursor Conditions: Find out the difference between monoclonal gammopathy of undetermined significance (MGUS) and...
91
- Dec 15, 2021
Multiple Myeloma Research Foundation - MMRF's The Right Track Program | High Impact Topic (HIT)
MMRF's The Right Track(TM) Program: This HIT shows patients who have been diagnosed with multiple myeloma how to get on the right...
167
- Dec 13, 2021
Patient Symposium - MCRT Webcast Myeloma Crowd Round Table, 10/16/2021 - St. Louis, Missouri
MCRT Webcast - Myeloma Crowd Round Table Myeloma Crowd Round Tables program MCRT St. Louis, Missouri October 16, 2021 Personalized...
114